The high clinical mortality and economic burden posed by invasive fungal infections (IFIs),
along with significant agricultural crop loss caused by various fungal species, has resulted in …

The epidemiology of invasive candidiasis has evolved in recent years, warranting a review
of the changes and the implications for current and future diagnosis and treatment. The …

The qualified presumption of safety (QPS) was developed to provide a safety pre‐
assessment within EFSA for microorganisms. Strains belonging to QPS taxonomic units (TU …

Human fungal pathogens are attributable to a significant economic burden and mortality
worldwide. Antifungal treatments, although limited in number, play a pivotal role in …

Aedes spp. are a major public health concern due to their ability to be efficient vectors of
dengue, Chikungunya, Zika, and other arboviruses. With limited vaccines available and no …

Although not as ubiquitous as antibacterial susceptibility testing, antifungal susceptibility
testing (AFST) is a tool of increasing importance in clinical microbiology laboratories. The …

Data on the epidemiology of invasive candidiasis (IC) and the antifungal susceptibility of
Candida isolates in China are still limited. Here we report on surveillance for IC from the …

Clonal expansion of fluconazole resistant (FLZ-R) Candida parapsilosis isolates is
increasingly being identified in many countries, while there is no study exploring the …

An online survey of mycology laboratories in seven Asian countries was conducted to
assess the status, competence, and services available. Country representatives from the …

Candida and Cryptococcus affect millions of people yearly, being responsible for a wide
array of clinical presentations, including life‐threatening diseases. Interestingly, most human …